ABOUT US

CMC Contrast  AB is a privately owned drug development company developing CMC-001, a novel contrast agent for use in liver MRI.

PIPELINE

CMC-001 is an investigational new drug for diagnostic use as a MRI contrast agent for enhancement of the liver. 

INVESTORS

The investors behind CMC Contrast AB are Sunstone Capital and ├śresund Healthcare.